What is STERILEX?
STERILX is a prominent leader in developing advanced microbial control solutions. Headquartered in Hunt Valley, Maryland, the company offers a portfolio of proprietary, award-winning biofilm-control biocides, broad-spectrum disinfectants, and rapid biofilm diagnostic tools. These innovative products serve critical applications across various sectors, including food and beverage protection, animal health, and water treatment, underscoring STERILX's commitment to public health and safety through cutting-edge technology.
How much funding has STERILEX raised?
STERILEX has raised a total of $745K across 1 funding round:
Debt
$745K
Debt (2021): $745K with participation from PPP
Key Investors in STERILEX
PPP
Public-Private Partnership
What's next for STERILEX?
The recent enterprise-level investment signifies a strong vote of confidence in STERILX's business model and its capacity for market expansion. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and broaden the company's market reach. STERILX is poised to leverage this financial backing to solidify its position as an industry frontrunner in microbial control, potentially exploring new applications and strategic partnerships to drive future success.
See full STERILEX company page
